• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18637 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Alirocumab for patients with hypercholesterolemia]
2019     NIHR Health Technology Assessment programme Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [PET-CT in patients with head and neck cancer diagnosis]
2019     NIHR Health Technology Assessment programme Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT
2019     NIHR Health Services and Delivery Research programme Evaluation of specialist nursing support for carers of people with dementia
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Relex® SMILE® surgery for refractive errors]
2019     NIHR Health Services and Delivery Research programme Understanding and enhancing how hospital staff learn from and act on patient experience data
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Liraglutide in obese and overweight patients]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Respiratory polygraphy for obstructive sleep apnea syndrome]
2019     NIHR Health Services and Delivery Research programme A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Thiazolidinediones for type 2 diabetes mellitus]
2019     NIHR Health Technology Assessment programme Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
2019     NIHR Health Technology Assessment programme Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron-emission tomography for breast cancer]
2019     NIHR Health Technology Assessment programme A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT
2019     Center for Evidence-based Practice (CEP) The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Center for Evidence-based Practice (CEP) Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Kinanthropometric nutritional assessment]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Center for Evidence-based Practice (CEP) Guidelines for Supplementary Feedings of Newborn Infants
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [High frequency chest compression vest for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2019     NIHR Health Technology Assessment programme Developing an intervention around referral and admissions to intensive care: a mixed-methods study
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Cerliponase alfa in neuronal ceroid lipofuscinosis type 2]
2019     NIHR Health Technology Assessment programme Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Prolotherapy in chronic musculoskeletal disorders]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous cement discoplasty for the treatment of degenerative scoliosis in the elderly]
2019     NIHR Health Technology Assessment programme Treatment of first-time traumatic anterior shoulder dislocation UK.TASH-D Study
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Shear-wave elastography for liver fibrosis]
2019     NIHR Health Services and Delivery Research programme The changing general practitioner workforce: the development of policies and strategies aimed at retaining experienced GPs and those taking a career break in direct patient care (ReGROUP)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Alphanate - von Willebrand disease]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Bendamustine as first line therapy for indolent non-Hodgkin’s lymphoma]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Erenumab in migraine prevention]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annulus Fibrosus Repair after lumbar discectomy
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [4CMenB vaccine for primary vaccination]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Teriparatide in biphosphonate-resistant osteoporosis and high fracture risk]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Immunocyanin in urothelial bladder cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Central auditory processing disorder diagnosis]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Selexipag in pulmonary hypertension]
2019     NIHR Health Technology Assessment programme Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allograft for anterior and posterior cruciate ligament reconstruction
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Holmium laser enucleation in benign prostatic hyperplasia]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [No-scalpel versus conventional vasectomy]
2019     NIHR Health Services and Delivery Research programme PRESENT: Patient Reported Experience Survey Engineering of Natural Text: developing practical automated analysis and dashboard representations of cancer survey freetext answers
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     National Committee for Technology Incorporation (CONITEC) [Diagnostic tests for thrombophilia in pregnancy]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Quantitative electroencephalography]
2019     NIHR Health Technology Assessment programme Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Reiki therapy in anxiety, depression and pain]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hip arthroscopy for painful hip treatment]
2019     NIHR Health Technology Assessment programme Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Prostate rectum spacing in prostate radiation therapy]
2019     NIHR Health Technology Assessment programme Anaesthetic analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Endovascular thrombectomy in acute ischemic stroke]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Deep anterior lamellar keratoplasty in keratoconus]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Shoulder prosthesis in complex proximal humeral fractures]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Implantable cardiac monitors in syncope of unknown etiology]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Rapid on-site evaluations of cytological punctures]
2019     NIHR Health Technology Assessment programme Manualised cognitive behavioural therapy in treating depression in advanced cancer: the CanTalk RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Per-oral endoscopic myotomy (POEM) in achalasia]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography: usefulness in glaucoma, diabetic retinopathy and age-related macular degeneration]
2019     NIHR Health Technology Assessment programme Cabozantinib and vandatinib for treating advanced or metastatic medullary thyroid cancer (ID56)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Video head impulse test in vertigo]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Palivizumab for the prevention of respiratory syncytial virus lower respiratory tract infections]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Sacral nerve stimulation/neuromodulation in bladder and/or bowel incontinence]
2019     NIHR Health Technology Assessment programme An evaluation of the feasibility of conducting a randomised clinical trial to evaluate the clinical and cost-effectiveness of a more permissive temperature threshold for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility study
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Eposterior tibial nerve stimulation in overactive bladder and bowel incontinence]
2019     NIHR Health Technology Assessment programme Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: anticoagulant therapy]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Pelvic vein embolization or sclerotherapy in pelvic congestion syndrome]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review